Immune Thrombocytopenia: Difference between revisions
Homa Najafi (talk | contribs) No edit summary |
Homa Najafi (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Immune Thrombocytopenia}} | {{Immune Thrombocytopenia}} | ||
'''For patient information, click [[Immune Thrombocytopenia (patient information)|here]]''' | |||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Maryam}} | ||
{{SK}} | {{SK}} |
Latest revision as of 21:06, 18 January 2021
Immune Thrombocytopenia Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Immune Thrombocytopenia On the Web |
American Roentgen Ray Society Images of Immune Thrombocytopenia |
Risk calculators and risk factors for Immune Thrombocytopenia |
For patient information, click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maryam Barkhordarian, M.D.[2]
Synonyms and keywords:
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Immune Thrombocytopenia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic study of choice | History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-Ray Findings | Echocardiography and Ultrasound | CT-Scan Findings | MRI Findings | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Interventions | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies